San Diego, CA – Enlyte recently released part 2 of its 2023 Annual Pharmacy Solutions Drug Trends Report. The goal of the full report, which is being issued in four segments over several months, is to provide an overall picture of drug utilization and cost trends in workers’ comp to equip industry professionals with useful insights for pharmacy management.
Part 2 of the report focuses on important aggregate prescribing patterns for in-and out-of-network prescriptions.
Out-of-network prescriptions represent a significant opportunity for clinical and cost controls and can often be associated with high-cost drugs.
By leveraging both bill review and pharmacy data, Enlyte provides additional visibility into transactions from third-party billers, physician dispensers, and co-mingled bills to get a more complete picture.
The report looks at prescription trends for:
- Generics
- Top therapeutic classes
- Opioid utilization
- Claim age, and more
View the report: Enlyte Pharmacy Solutions Drug Trends Report Part 2: Pharmacy Networks (PDF)
Source: Enlyte
Disclosure:
Enlyte is a WorkCompWire ad partner.
This is NOT a paid placement.